Davita Inc vs Warner Music Group Corp — how do they compare? Davita Inc trades at $179.56 (market cap $11.29B), while Warner Music Group Corp trades at $29.4 (market cap $15.12B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Warner Music Group Corp pays a 2.77% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Warner Music Group Corp for 96 Days on average.
| DVA | WMG | |
|---|---|---|
Market Cap | $11.29B | $15.12B |
Volume | 582,204 | 2,966,414 |
Sector | Health | Media |
52-Week High | $240.96 | $34.72 |
52-Week Low | $103.87 | $23.65 |
Typical Hold Time | 113 Days | 96 Days |
Enterprise Value | $24.01B | $19.42B |
Dividend Yield | — | 2.77% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
Warner Music Group (WMG) trades at $28.16, up 1.99% today, with a bullish technical signal and strong analyst support. Recent earnings show revenue growth to $6.71B in 2025, though net income margin dipped to 5.44%. The company is actively engaging in AI partnerships and licensing renewals, positioning for future growth in the evolving media landscape.
The outlook for WMG is positive, driven by streaming growth and strategic AI initiatives, with a consensus price target of $39.50 implying significant upside. Risks include margin pressure and competitive dynamics in the music industry, but institutional buying and a 'Moderate Buy' consensus suggest confidence in its long-term value.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →